Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients

Figure 1 Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response [figure omitted; refer to PDF] Results Median duration of treatment was 414 (29-6...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric Rheumatology 2011-09, Vol.9 (S1), p.P12-P12, Article P12
Main Authors: Bader-Meunier, B, Hachulla, P, Kuemmerle-Deschner, J, Gattorno, M, Patel, N, Preiss, R, Lheritier, K, Imagawa, T, Nishikomori, R, Takada, H, Heike, T, Hara, T, Yokota, S
Format: Article
Language:English
Subjects:
Comparative analysis
Drug therapy
Poster Presentation
Rheumatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page P12
container_issue S1
container_start_page P12
container_title Pediatric Rheumatology
container_volume 9
creator Bader-Meunier, B
Hachulla, P
Kuemmerle-Deschner, J
Gattorno, M
Patel, N
Preiss, R
Lheritier, K
Imagawa, T
Nishikomori, R
Takada, H
Heike, T
Hara, T
Yokota, S
description Figure 1 Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response [figure omitted; refer to PDF] Results Median duration of treatment was 414 (29-687) days in WP and 337 days (59-373 days) in JP.
doi_str_mv 10.1186/1546-0096-9-S1-P12
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4abf4ee77a504e72b02044469825197a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4abf4ee77a504e72b02044469825197a</doaj_id><sourcerecordid>2503743211</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2972-e6536767cdb6f176e74cf51dec713f622154ab14b61b78e60ffc3a2e529292663</originalsourceid><addsrcrecordid>eNp1ksGO0zAQhiMEEsvCC3CyOMEhYDuJXXNAqsoCi1aiUkEcrYkz6bo0drCTojwQ74mzXVVUAvlga8b6_pn5J8ueM_qasYV4w6pS5JQqkat8w_I14w-yi1Pw4V_vx9mTGHeUVhWV1UX2-72P1m1JD8OAwUXiW2LAwQ_rxg5qYt2csuiGSH7Z4ZaswuT7KViXL2P0xsKADVljsL6xhmwm1wTfYSQvV8v15tVbsiTGdz2EBDkgSeT9FO2dDJA4jM00S3zHOKuTA4Y4RvIZenAY8ST9NHvUwj7is_v7Mvv24err6lN-8-Xj9Wp5k9dcSZ6jqAohhTRNLVomBcrStBVr0EhWtILzNAWoWVkLVssFCtq2pgCOFVfpCFFcZtdHbuNhp_tgOwiT9mD1XcCHrYYwWLNHnUBtiSglVLREyWvKaVmWQi14xZSExHp3ZPVj3WFjUh8B9mfQ84yzt3rrD7pgauYkwNURUFv_H8B5Jg1azz7r2Wet9IbptAiJ8-K-kOB_jmnSeufHkIyIWlHOpRRq7pwfP5ngYwzYnnQY1fOK_Yv8B4B8yBY</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902277696</pqid></control><display><type>article</type><title>Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients</title><source>PubMed (Medline)</source><source>Publicly Available Content (ProQuest)</source><creator>Bader-Meunier, B ; Hachulla, P ; Kuemmerle-Deschner, J ; Gattorno, M ; Patel, N ; Preiss, R ; Lheritier, K ; Imagawa, T ; Nishikomori, R ; Takada, H ; Heike, T ; Hara, T ; Yokota, S</creator><creatorcontrib>Bader-Meunier, B ; Hachulla, P ; Kuemmerle-Deschner, J ; Gattorno, M ; Patel, N ; Preiss, R ; Lheritier, K ; Imagawa, T ; Nishikomori, R ; Takada, H ; Heike, T ; Hara, T ; Yokota, S</creatorcontrib><description>Figure 1 Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response [figure omitted; refer to PDF] Results Median duration of treatment was 414 (29-687) days in WP and 337 days (59-373 days) in JP.</description><identifier>ISSN: 1546-0096</identifier><identifier>EISSN: 1546-0096</identifier><identifier>DOI: 10.1186/1546-0096-9-S1-P12</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Comparative analysis ; Drug therapy ; Poster Presentation ; Rheumatology</subject><ispartof>Pediatric Rheumatology, 2011-09, Vol.9 (S1), p.P12-P12, Article P12</ispartof><rights>2011 Bader-Meunier et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright ©2011 Bader-Meunier et al; licensee BioMed Central Ltd. 2011 Bader-Meunier et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194469/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194469/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Bader-Meunier, B</creatorcontrib><creatorcontrib>Hachulla, P</creatorcontrib><creatorcontrib>Kuemmerle-Deschner, J</creatorcontrib><creatorcontrib>Gattorno, M</creatorcontrib><creatorcontrib>Patel, N</creatorcontrib><creatorcontrib>Preiss, R</creatorcontrib><creatorcontrib>Lheritier, K</creatorcontrib><creatorcontrib>Imagawa, T</creatorcontrib><creatorcontrib>Nishikomori, R</creatorcontrib><creatorcontrib>Takada, H</creatorcontrib><creatorcontrib>Heike, T</creatorcontrib><creatorcontrib>Hara, T</creatorcontrib><creatorcontrib>Yokota, S</creatorcontrib><title>Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients</title><title>Pediatric Rheumatology</title><description>Figure 1 Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response [figure omitted; refer to PDF] Results Median duration of treatment was 414 (29-687) days in WP and 337 days (59-373 days) in JP.</description><subject>Comparative analysis</subject><subject>Drug therapy</subject><subject>Poster Presentation</subject><subject>Rheumatology</subject><issn>1546-0096</issn><issn>1546-0096</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ksGO0zAQhiMEEsvCC3CyOMEhYDuJXXNAqsoCi1aiUkEcrYkz6bo0drCTojwQ74mzXVVUAvlga8b6_pn5J8ueM_qasYV4w6pS5JQqkat8w_I14w-yi1Pw4V_vx9mTGHeUVhWV1UX2-72P1m1JD8OAwUXiW2LAwQ_rxg5qYt2csuiGSH7Z4ZaswuT7KViXL2P0xsKADVljsL6xhmwm1wTfYSQvV8v15tVbsiTGdz2EBDkgSeT9FO2dDJA4jM00S3zHOKuTA4Y4RvIZenAY8ST9NHvUwj7is_v7Mvv24err6lN-8-Xj9Wp5k9dcSZ6jqAohhTRNLVomBcrStBVr0EhWtILzNAWoWVkLVssFCtq2pgCOFVfpCFFcZtdHbuNhp_tgOwiT9mD1XcCHrYYwWLNHnUBtiSglVLREyWvKaVmWQi14xZSExHp3ZPVj3WFjUh8B9mfQ84yzt3rrD7pgauYkwNURUFv_H8B5Jg1azz7r2Wet9IbptAiJ8-K-kOB_jmnSeufHkIyIWlHOpRRq7pwfP5ngYwzYnnQY1fOK_Yv8B4B8yBY</recordid><startdate>20110914</startdate><enddate>20110914</enddate><creator>Bader-Meunier, B</creator><creator>Hachulla, P</creator><creator>Kuemmerle-Deschner, J</creator><creator>Gattorno, M</creator><creator>Patel, N</creator><creator>Preiss, R</creator><creator>Lheritier, K</creator><creator>Imagawa, T</creator><creator>Nishikomori, R</creator><creator>Takada, H</creator><creator>Heike, T</creator><creator>Hara, T</creator><creator>Yokota, S</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><general>BMC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>AAENX</scope><scope>AAFGM</scope><scope>ABUWG</scope><scope>ADAJB</scope><scope>ADZZV</scope><scope>AFCXM</scope><scope>AFKRA</scope><scope>AGAJT</scope><scope>AGBVP</scope><scope>AQTIP</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQCXX</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110914</creationdate><title>Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients</title><author>Bader-Meunier, B ; Hachulla, P ; Kuemmerle-Deschner, J ; Gattorno, M ; Patel, N ; Preiss, R ; Lheritier, K ; Imagawa, T ; Nishikomori, R ; Takada, H ; Heike, T ; Hara, T ; Yokota, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2972-e6536767cdb6f176e74cf51dec713f622154ab14b61b78e60ffc3a2e529292663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Comparative analysis</topic><topic>Drug therapy</topic><topic>Poster Presentation</topic><topic>Rheumatology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bader-Meunier, B</creatorcontrib><creatorcontrib>Hachulla, P</creatorcontrib><creatorcontrib>Kuemmerle-Deschner, J</creatorcontrib><creatorcontrib>Gattorno, M</creatorcontrib><creatorcontrib>Patel, N</creatorcontrib><creatorcontrib>Preiss, R</creatorcontrib><creatorcontrib>Lheritier, K</creatorcontrib><creatorcontrib>Imagawa, T</creatorcontrib><creatorcontrib>Nishikomori, R</creatorcontrib><creatorcontrib>Takada, H</creatorcontrib><creatorcontrib>Heike, T</creatorcontrib><creatorcontrib>Hara, T</creatorcontrib><creatorcontrib>Yokota, S</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Pediatric Rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bader-Meunier, B</au><au>Hachulla, P</au><au>Kuemmerle-Deschner, J</au><au>Gattorno, M</au><au>Patel, N</au><au>Preiss, R</au><au>Lheritier, K</au><au>Imagawa, T</au><au>Nishikomori, R</au><au>Takada, H</au><au>Heike, T</au><au>Hara, T</au><au>Yokota, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients</atitle><jtitle>Pediatric Rheumatology</jtitle><date>2011-09-14</date><risdate>2011</risdate><volume>9</volume><issue>S1</issue><spage>P12</spage><epage>P12</epage><pages>P12-P12</pages><artnum>P12</artnum><issn>1546-0096</issn><eissn>1546-0096</eissn><abstract>Figure 1 Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response Step-wise up-titrations in patients (WP and Japanese) who did not achieve or remain in complete response [figure omitted; refer to PDF] Results Median duration of treatment was 414 (29-687) days in WP and 337 days (59-373 days) in JP.</abstract><cop>London</cop><pub>BioMed Central</pub><doi>10.1186/1546-0096-9-S1-P12</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1546-0096
ispartof Pediatric Rheumatology, 2011-09, Vol.9 (S1), p.P12-P12, Article P12
issn 1546-0096
1546-0096
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4abf4ee77a504e72b02044469825197a
source PubMed (Medline); Publicly Available Content (ProQuest)
subjects Comparative analysis
Drug therapy
Poster Presentation
Rheumatology
title Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T17%3A53%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dosing%20patterns%20of%20canakinumab%20in%20patients%20with%20Cryopyrin-Associated%20Periodic%20Syndromes%20(CAPS):%20A%20comparative%20analysis%20of%20a%20study%20in%20Western%20versus%20Japanese%20patients&rft.jtitle=Pediatric%20Rheumatology&rft.au=Bader-Meunier,%20B&rft.date=2011-09-14&rft.volume=9&rft.issue=S1&rft.spage=P12&rft.epage=P12&rft.pages=P12-P12&rft.artnum=P12&rft.issn=1546-0096&rft.eissn=1546-0096&rft_id=info:doi/10.1186/1546-0096-9-S1-P12&rft_dat=%3Cproquest_doaj_%3E2503743211%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b2972-e6536767cdb6f176e74cf51dec713f622154ab14b61b78e60ffc3a2e529292663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=902277696&rft_id=info:pmid/&rfr_iscdi=true